Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nexilin F-actin binding protein (NEXN) is a cytoskeletal protein that binds filamentous actin and is essential for maintaining the structural integrity of Z-discs in cardiomyocytes and skeletal muscle. It is crucial for mechanical stability during muscle contraction and tissue remodeling, particularly in the heart and vascular smooth muscle. NEXN mutations impair myofibrillar structure, leading to dilated and hypertrophic cardiomyopathies, and may be implicated in vascular remodeling processes. No direct drugs target NEXN, but pathogenic variants serve as important genetic biomarkers for inherited cardiomyopathies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nexilin F-actin binding protein (NEXN).